Benign monoclonal gammopathy: a reassessment of the problem.

Disease associations of clonally restricted serum immunoglobulin (Ig) abnormalities were examined using methods for detecting and characterizing homogeneous Ig that are approximately forty times more sensitive than either cellulose acetate zone electrophoresis or immunoelectrophoresis. Medical records of three hundred five patients with clonally-restricted serum immunoglobulins, including 100 monoclonal gammopathies, and 205 immune complex/oligoclonal patterns were reviewed to obtain the attending physician's discharge diagnosis. Our data confirm lymphoproliferative disorders as the most frequent cause of monoclonal gammopathy (63% of our cases). However, in contrast to earlier reports, we found little evidence to support an association between monoclonal gammopathy and non-reticular malignancy. This does not mean our patients with these disorders had normal serum immunoglobulin patterns; rather, their qualitative abnormalities were, for the most part, not monoclonal. Instead, patients with these diseases had a high incidence of serum immune complexes and their antibody excess sequelae, oligoclonal patterns. Oligoclonal responses are noteworthy because Ig products of the individual clones do not always achieve equivalent serum concentrations, nor are the various clonal products synchronized with respect to the time at which they attain peak concentration. This creates a number of problems for laboratories attempting to characterize such abnormalities; 1) some analytical methods may only be capable of detecting the dominant clone of an oligoclonal pattern, and 2) analysis of a single specimen may yield erroneous results because the unique waxing and waning kinetic pattern of oligoclonal responses may preclude identification of all components at a single time point. We conclude that benign "monoclonal" gammopathies and circulating immune complex/oligoclonal Ig abnormalities occur in the same clinical situations and may be synonymous. The sensitivity of an individual laboratory's analytical methods would then determine which name is applied.

[1]  S. Ritzmann,et al.  Immune complexes: characteristics, clinical correlations, and interpretive approaches in the clinical laboratory. , 1982, Clinical chemistry.

[2]  A. Keshgegian Prevalence of small monoclonal proteins in the serum of hospitalized patients. , 1982, American journal of clinical pathology.

[3]  J. Jeppsson,et al.  Typing of genetic variants of alpha 1-antitrypsin by electrofocusing. , 1982, Clinical chemistry.

[4]  R. Kelly,et al.  Multiple clonally-restricted immunoglobulins in human sera: disease associations. , 1982, International archives of allergy and applied immunology.

[5]  T. Whiteside,et al.  Circulating and deposited immune complexes in patients with glomerular disease: immunopathologic correlations. , 1981, The American journal of pathology.

[6]  A. L. Latner,et al.  Microheterogeneity of serum myeloma immunoglobulins revealed by a technique of high resolution two‐dimensional electrophoresis , 1980 .

[7]  M. Scholl,et al.  Qualitative testing for circulating immune complexes by use of zone electrophoresis on agarose. , 1980, Clinical chemistry.

[8]  J. Jeppsson,et al.  Agarose gel electrophoresis. , 1979, Clinical chemistry.

[9]  J. Benbassat,et al.  Monoclonal immunoglobulin disorders: a report of 154 cases , 1976, The American journal of the medical sciences.

[10]  R. Ritchie,et al.  Immunofixation. I. General principles and application to agarose gel electrophoresis. , 1976, Clinical chemistry.

[11]  Colls Bm,et al.  Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases. , 1975 .

[12]  H. Fidler Hospital Insurance Scheme , 1973 .

[13]  A. Talerman,et al.  The Frequency of M-components in Sera of Patients with Solid Malignant Neoplasms , 1973, British Journal of Cancer.

[14]  E. Osserman,et al.  PATHOLOGIC CONDITIONS ASSOCIATED WITH PLASMA CELL DYSCRASIAS: A STUDY OF 806 CASES * , 1971, Annals of the New York Academy of Sciences.

[15]  P. Righetti,et al.  Isoelectric focusing in polyacrylamide gels. , 1971, Biochimica et biophysica acta.

[16]  Williams Rc,et al.  Studies of "benign" serum M-components. , 1969 .

[17]  R. Alexanian,et al.  Monoclonal gammopathy in human neoplasia , 1968, Cancer.

[18]  R. Krause,et al.  Streptococcal group-specific antibodies: occurrence of a restricted population following secondary immunization. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Hobbs Paraproteins, benign or malignant? , 1967, British medical journal.

[20]  M. Potter,et al.  Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin-oil adjuvant, heart-killed Staphylococcus mixtures. , 1960, Journal of the National Cancer Institute.